2019GINA 更新：轻度哮喘治疗的重要改变_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

 王长征

陆军军医大学新桥医院呼吸内科（重庆 400037）;

Corresponding author：

王长征, Email: czwang@netease.com

Keywords：

DOI：

10.7507/1671-6205.201909060

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 王长征. 2019GINA 更新：轻度哮喘治疗的重要改变. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(6): 509-510. doi: 10.7507/1671-6205.201909060 Copy

1.	O’Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med, 2018, 378(20): 1865-1876.
2.	Bateman ED, Reddel HK, O’Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med, 2018, 378(20): 1877-1887.
3.	Beasley R, Holliday M, Reddel HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med, 2019, 380(21): 2020-2030.
4.	Lazarus SC, Krishnan JA, King TS, et al. Mometasone or tiotropium in mild asthma with a low sputum eosinophil level. N Engl J Med, 2019, 380(21): 2009-2019.

Next Article
中美呼吸与危重症医学专科医师培训制度对比和思考

Chinese Journal of Respiratory and Critical Care Medicine

2019GINA 更新：轻度哮喘治疗的重要改变

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content